Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Genetics of Gne Myopathy in the Non-Jewish Persian Population Publisher Pubmed



Haghighi A1, 2, 3 ; Nafissi S4 ; Qurashi A5 ; Tan Z5 ; Shamshiri H4 ; Nilipour Y6 ; Haghighi A1, 2, 3 ; Desnick RJ5 ; Kornreich R5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Genetics, Harvard Medical School, 77 Ave Louis Pasteur, Boston, 02115, MA, United States
  2. 2. Department of Medicine, Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA, United States
  3. 3. Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
  4. 4. Department of Neurology, Iranian Center of Neurological Research, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran
  5. 5. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Box 1497, One Gustave L. Levy Place, New York, 10029, NY, United States
  6. 6. Department of Pathology, Pediatric Pathology Research Center, Mofid Children Hospital, Shahid Beheshti Medical University, Tehran, Iran
  7. 7. Toronto General Hospital, University of Toronto, Toronto, ON, Canada

Source: European Journal of Human Genetics Published:2016


Abstract

GNE myopathy is an autosomal recessive adult-onset disorder characterized by progressive muscle atrophy and weakness, initially involving the distal muscles, while often sparing the quadriceps. It is caused by variants in the GNE gene that encodes a key bifunctional enzyme in the sialic acid biosynthetic pathway. We investigated the clinical and molecular characteristics of 18 non-Jewish Persian patients from 11 unrelated GNE myopathy families. In addition, we reviewed the previously reported cases and suggest genotype-phenotype correlations for the identified variants. Comprehensive clinical and laboratory evaluations were carried out. Sequencing of the GNE gene was performed using genomic DNA from the patients. Screening of the identified variants was performed in all relevant family members. Molecular analyses identified three causative homozygous GNE variants in 11 families: c.2228T>C (p. M743T) in 7, c.830G>A (p.R277Q) in 2, and one novel variation (c.804G>A) in 2 families that results in a synonymous codon change (p.L268=) and likely creates a novel splice site affecting the protein function. This study confirms that c.2228T>C (p.M743T) is the most prevalent disease-causing variant in the non-Jewish Persian population, but other GNE variants can cause GNE myopathy in this population. The patients with all three different variants had similar ages of onset. The youngest patient was an 18-year-old girl in whom the c.830G>A (p.R277Q) variant was identified, whereas the oldest onset age (31 years) was seen in a male patient with c.804G>A (p.L268=). The results of this investigation expand our knowledge about the genotype-phenotype correlations in GNE myopathy and aid in clinical management and therapeutic interventions. © 2016 Macmillan Publishers Limited All rights reserved.